Self-injurious behavior in rats produced by intranigral microinjection of GABA agonists

Pharmacology, Biochemistry, and Behavior
A A Baumeister, G D Frye

Abstract

Bilateral injection of the GABA agonist muscimol (10-300 ng) into the caudal substantia nigra (pars reticulata) of rats produced dose-dependent stereotyped gnawing and self-biting. Limiting the opportunity to gnaw on inanimate objects shifted the dose-response curve for muscimol-induced self-injurious behavior (SIB) to the left and increased the maximum incidence of SIB. Microinjection of muscimol (30 ng) into the rostral and caudal regions of the substantia nigra were equally effective in producing SIB, though the incidence of SIB decreased sharply when muscimol was injected 1 mm rostral or caudal to the substantia nigra. Bilateral intranigral injection of THIP (100-1000 ng) and (+/-)baclofen (100-1000 ng) induced a low incidence of SIB. However, neither IP administration of picrotoxin (5 mg/kg) or simultaneous microinjection of (+)bicuculline methiodide (BMI; 300 or 1000 ng) along with muscimol (30 ng) blocked muscimol-induced SIB. In fact, (+)BMI increased the occurrence of self-biting and reduced the latency to onset of SIB. The involvement of GABAergic mechanisms in muscimol-induced SIB is discussed.

References

Sep 1, 1978·Journal of Autism and Childhood Schizophrenia·S R SchroederJ Dalldorf
Oct 1, 1976·Pediatric Research·H G JohnsonW Friesen
Sep 1, 1976·Journal of Autism and Childhood Schizophrenia·W L Nyhan
Feb 1, 1975·European Journal of Pharmacology·A RazzakS Ueki
May 1, 1969·Life Sciences·E GenoveseN Bolego-Zonta
Nov 5, 1981·The New England Journal of Medicine·K G LloydI H Fox
Jun 1, 1982·Pharmacology, Biochemistry, and Behavior·K Mueller, W L Nyhan
Mar 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·L K Rägo, A M Zarkovsky
Sep 1, 1983·Journal of Neurochemistry·A G Chapman, M C Evans
Oct 1, 1982·Pharmacology, Biochemistry, and Behavior·K MuellerW L Nyhan
Mar 7, 1980·European Journal of Pharmacology·J Arnt, J Scheel-Krüger
Jun 1, 1981·Pharmacology, Biochemistry, and Behavior·H G Lloyd, T W Stone

❮ Previous
Next ❯

Citations

Jun 1, 1993·Journal of Behavior Therapy and Experimental Psychiatry·R W Montgomery, T Ayllon
Aug 1, 1989·Pharmacology, Biochemistry, and Behavior·R T MatthewsG D Frye
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·V A RamseyH C Rosenberg
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·A A Baumeister, G D Frye
Jan 1, 1989·Psychopharmacology Bulletin·C T Gualtieri, S R Schroeder
Sep 1, 1990·Brain Research Bulletin·H A JinnahT Friedmann
Sep 1, 1990·Brain Research Bulletin·G R BreeseR A Mueller
Dec 22, 1999·Physiology & Behavior·M F HawkinsM A Duke
Dec 22, 1999·Brain & Development·E FazziG Lanzi
Nov 27, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew D ChangIrving M Reti
Jan 31, 2012·Journal of Intellectual Disability Research : JIDR·A M Muehlmann, M H Lewis
Nov 2, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·David DybdalKaren Gale
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·A A Baumeister, J A Sevin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.